Campuses: FH.com Home button

Transitional Cell Carcinoma (TCC)

Why Choose Florida Hospital?

Transitional cell carcinoma (TCC) is a type of cancer that attacks the transitional cells known as the urothelial, the internal lining that coats the urinary system. TCC is also recognized as the leading cause of bladder cancer in the United States. If TCC patients go without the proper treatment, the transitional cells of the urinary system such as the bladder, urethra, and ureters may progress into a severe health crisis including death. For the most part, transitional cell carcinoma (TCC) may spread to nearby organs, tissues, lymph nodes and reach other vital components that can disrupt critical functions. Urologists at Florida Hospital are dedicated to exploring risk factors of transitional cell carcinoma (TCC), can determine what type of urinary cancer is present, will order the most reliable tests to screen for bladder cancer, and can devise a treatment plan with a good prognosis. If urinary system problems elevate blood pressure, create intense pain, and cause an obstruction, call 9-1-1 immediately.     

Contact Us

Learn

Transitional cell carcinoma (TCC) is known as the most common cause of bladder cancer, making up the majority of all bladder cancers in the United States. TCC is capable of forming within any region of the urinary system, causing urinary cancer and/or bladder cancer to develop. 

Bladder cancer is found to attack male members (white males are diagnosed twice as much as African American males) more often than women, with the majority of people affected being 55-years and older. If left untreated, TCC may become a serious condition with debilitating effects. Early detection of TCC can lead to a favorable prognosis.

Locations for Transitional Cell Carcinoma (TCC)